Acta Med. 2008, 51: 191-195

https://doi.org/10.14712/18059694.2017.23

Quantitative Analysis of Expression Level of BCL2 and BAX Genes in Hep-2 and HL-60 Cells after Treatment with Etoposide

Dita Královcováa, Marcela Pejchalováa, Emil Rudolfb, Miroslav Červinkab

aUniversity of Pardubice, Faculty of Chemical-Technology, Department of Biological and Biochemical Sciences, Pardubice, Czech Republic
bCharles University in Prague, Faculty of Medicine in Hradec Králové, Department of Medical Biology and Genetics, Hradec Králové, Czech Republic

Received February 1, 2008
Accepted August 1, 2008

References

1. Bailly C. Topoisomerase I poisons and suppressors as anticancer drugs. Curr Med Chem. 2000; 7(1):39–58. <https://doi.org/10.2174/0929867003375489>
2. Balasubashini MS, Karthigayan S, Somasundaram ST, Balasubramanian T, Rukkumani R, Menon VP. FV peptide induces apoptosis in HEp 2 and HeLa cells: an insight into the mechanism of induction. J Carcinog. 2006; 5:27. <https://doi.org/10.1186/1477-3163-5-27> <PubMed>
3. Baldwin EL, Osheroff N. Etoposide, topoisomerase II and cancer. Curr Med Chem Anticancer Agents. 2005; 5(4):363–72. <https://doi.org/10.2174/1568011054222364>
4. Bjorling-Poulsen M, Issinger OG. cDNA array analysis of alterations in gene expression in the promyelocytic leukemia cell line, HL-60, after apoptosis induction with etoposide. Apoptosis. 2003; 8(4):377–88. <https://doi.org/10.1023/A:1024177119658>
5. Cervinka M, Bereiter-Hahn J, Peychl J, Rudolf E, Cervinkov Z. The role of mitochondria in apoptosis induced in vitro. Gen Physiol Biophys. 1999; 18:33–40.
6. Cervinka M, Cerman J, Rudolf E. Apoptosis in Hep2 cells treated with etoposide and colchicine. Cancer Detect Prev. 2004; 28(3):214–26. <https://doi.org/10.1016/j.cdp.2004.03.002>
7. Duran N., Allahverdiyev AM, Cetiner S. Flow Cytometric Analysis of the Effects of Methotrexate and Vepesid on the HEp-2 Cell Cycle. Turk J Med Sci. 2001; 31:187–192.
8. Eliseev RA, Gunter KK, Gunter TE. Bcl-2 prevents abnormal mitochondrial proliferation during etoposide-induced apoptosis. Exp Cell Res. 2003; 289(2): 275–81. <https://doi.org/10.1016/S0014-4827(03)00278-7>
9. Filippovich IV, Sorokina NI, Lisbona A, Chrel M, Chatal JF. Radiation-induced apoptosis in human myeloma cell line increases BCL-2/BAX dimer formation and does not result in BAX/BAX homodimerization. Int J Cancer. 2001; 92(5):651–60. <https://doi.org/10.1002/1097-0215(20010601)92:5<651::AID-IJC1248>3.0.CO;2-7>
10. Finucane DM, Bossy-Wetzel E, Waterhouse NJ, Cotter TG, Green DR. Bax-induced caspase activation and apoptosis via cytochrome c release from mitochondria is inhibitable by Bcl-xL. J Biol Chem. 1999; 274(4):2225–33. <https://doi.org/10.1074/jbc.274.4.2225>
11. Floros KV, Talieri M, Scorilas A. Topotecan and methotrexate alter expression of the apoptosis-related genes BCL2, FAS and BCL2L12 in leukemic HL-60 cells. Biol Chem. 2006; 387(12):1629–33. <https://doi.org/10.1515/BC.2006.203>
12. Floros KV, Thomadaki H, Florou D, Talieri M, Scorilas A. Alterations in mRNA expression of apoptosis-related genes BCL2, BAX, FAS, caspase-3, and the novel member BCL2L12 after treatment of human leukemic cell line HL60 with the antineoplastic agent etoposide. Ann N Y Acad Sci. 2006; 1090:89–97. <https://doi.org/10.1196/annals.1378.009>
13. Floros KV, Thomadaki H, Lallas G, Katsaros N, Talieri M, Scorilas A. Cisplatininduced apoptosis in HL-60 human promyelocytic leukemia cells: differential expression of BCL2 and novel apoptosis-related gene BCL2L12. Ann N Y Acad Sci. 2003; 1010:153–8. <https://doi.org/10.1196/annals.1299.025>
14. Higginbottom K, Jahnke U, Newland AC, Cotter FE, New alternative phosphorylation sites on the cyclin dependent kinase 1/cyclin a complex in p53-deficient human cells treated with etoposide: possible association with etoposide-induced apoptosis. Apoptosis 2007; 12(10):1847–55. <https://doi.org/10.1007/s10495-007-0104-6>
15. Ikeguchi M, Hirooka Y, Kaibara N. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma. Cancer 2002; 95(9):1938–45. <https://doi.org/10.1002/cncr.10898>
16. Ikeguchi M, Nakamura S, Kaibara N. Quantitative analysis of expression levels of bax, bcl-2, and survivin in cancer cells during cisplatin treatment. Oncol Rep. 2002; 9(5):1121–6.
17. Jakubowicz-Gil J, Paduch R, Gawron A, Kandefer-Szersze M. The effect of heat shock, cisplatin, etoposide and quercetin on Hsp27 expression in human normal and tumour cells. Folia Histochem Cytobiol. 2002; 40(1):31–5.
18. Kluza J, Mazinghien R, Irwin H, Hartley JA, Bailly C. Relationships between DNA strand breakage and apoptotic progression upon treatment of HL-60 leukemia cells with tafluposide or etoposide. Anticancer Drugs. 2006; 17(2):155–64. <https://doi.org/10.1097/00001813-200602000-00006>
19. Kravtsov VD, Daniel TO, Koury MJ. Comparative analysis of different methodological approaches to the in vitro study of drug-induced apoptosis. Am J Pathol. 1999; 155(4):1327–39. <https://doi.org/10.1016/S0002-9440(10)65235-2> <PubMed>
20. Li P, Budihardjo I et al. Cytochrome c and dATP-dependent formation of Apaf- 1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997; 91(4): 479–89. <https://doi.org/10.1016/S0092-8674(00)80434-1>
21. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using realtime quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25(4):402–8. <https://doi.org/10.1006/meth.2001.1262>
22. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993; 74(4): 609–19. <https://doi.org/10.1016/0092-8674(93)90509-O>
23. Parihar A, Parihar MS, Ghafourifar P. Significance of mitochondrial calcium and nitric oxide for apoptosis of human breast cancer cells induced by tamoxifen and etoposide. Int J Mol Med. 2008; 21(3):317–24.
24. Rózalski M, Mirowski M, Balcerczak E, Krajewska U, Mynarski W, Wierzbicki R. Induction of caspase 3 activity, bcl-2 bax and p65 gene expression modulation in human acute promyelocytic leukemia HL-60 cells by doxorubicin with amifostine. Pharmacol Rep. 2005; 57(3):360–6.
25. Rudolf E, Cervinka M. Membrane blebbing in cancer cells treated with various apoptotic inducers. Acta Medica 2005; 48(1):29–34.
26. Rudolf E, Peychl J, Novak J, Cervinka M. Apoptosis – when the cells begin to dance. Front Biosci. 2000; 5:F1–2. <https://doi.org/10.2741/A486>
27. Sargent JM, Elgie AW, Williamson CJ, Hill BT. Ex vivo effects of the dual topoisomerase inhibitor tafluposide (F 11782) on cells isolated from fresh tumor samples taken from patients with cancer. Anticancer Drugs 2003; 14(6): 467–73. <https://doi.org/10.1097/00001813-200307000-00013>
28. Singh S, Chhipa RR, Vijayakumar MV, Bhat MK. DNA damaging drugs-induced down-regulation of Bcl-2 is essential for induction of apoptosis in high-risk HPVpositive HEp-2 and KB cells. Cancer Lett. 2006; 236(2):213–21. <https://doi.org/10.1016/j.canlet.2005.05.024>
29. Thomas D, Yang H, Boffa DJ et al. Proapoptotic Bax is hyperexpressed in isolated human islets compared with antiapoptotic Bcl-2. Transplantation 2002; 74(11):1489–96. <https://doi.org/10.1097/00007890-200212150-00003>
30. Zuryn A, Grzanka A, Stepien A, Grzanka D, Debski R, Smolinski D. Expression of cyclin A in human leukemia cell line HL-60 following treatment with doxorubicin and etoposide: the potential involvement of cyclin A in apoptosis. Oncol Rep. 2007; 17(5):1013–9.
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive